IRLA
IRulya Therapeutics Inc. Common Stock
stockNASDAQ
At CloseOct 23, 2026 3:57:35 PM EDT
33.31USD+2.319%(+0.76)89,783
IRLA Financials
In Q2 FY 2026 (ended ), IRulya Therapeutics Inc. Common Stock (IRLA) reported net income of −$75.49M, operating cash flow of −$18.89M, and assets of $124M.
Loading financial statements…